Literature DB >> 10679931

Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart.

P S Zammit1, R G Kelly, D Franco, N Brown, A F Moorman, M E Buckingham.   

Abstract

Many cardiac genes are broadly expressed in the early heart and become restricted to the atria or ventricles as development proceeds. Additional transcriptional differences between left and right compartments of the embryonic heart have been described recently, in particular for a number of transgenes containing cardiac regulatory elements. We now demonstrate that three myosin genes which become transcriptionally restricted to the atria between embryonic day (E) 12.5 and birth, alpha-myosin heavy chain (MHC), myosin light chain (MLC) 1A and MLC2A, are coordinately downregulated in the compact myocardium of the left ventricle before that of the right ventricle. alpha-MHC protein also accumulates in the right, but not left, compact ventricular myocardium during this period, suggesting that this transient regionalization contributes to fktal heart function. dHAND and eHAND, basic helix-loop-helix transcription factors known to be expressed in the right and left ventricles respectively at E10. 5, remain regionalized between E12.5 and E14.5. Downregulation of alpha-MHC, MLC1A, and MLC2A in iv/iv embryos, which have defective left/right patterning, initiates in the morphological left (systemic) ventricle regardless of its anatomical position on the right or left hand side of the heart. This points to the importance of left/right ventricular differences in sarcomeric gene expression patterns during fktal cardiogenesis and indicates that these differences originate in the embryo in response to anterior-posterior patterning of the heart tube rather than as a result of cardiac looping. Dev Dyn 2000;217:75-85. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679931     DOI: 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  17 in total

1.  Depletion of lamina-associated polypeptide 1 from cardiomyocytes causes cardiac dysfunction in mice.

Authors:  Ji-Yeon Shin; Caroline Le Dour; Fusako Sera; Shinichi Iwata; Shunichi Homma; Leroy C Joseph; John P Morrow; William T Dauer; Howard J Worman
Journal:  Nucleus       Date:  2014-05-23       Impact factor: 4.197

2.  A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice.

Authors:  Séverine Allegra; Lamia Bouazza; Claire Benetollo; Jacques Yuan Li; Dominique Langlois
Journal:  Transgenic Res       Date:  2005-02       Impact factor: 2.788

3.  A mouse model for spatial and temporal expression of HGF in the heart.

Authors:  Ilan Riess; Valentina Sala; Christian Leo; Marco Demaria; Stefano Gatti; Simona Gallo; Amandine Fitou; Ombretta Boero; Renzo Levi; Ivan Cuccovillo; Fabiola Molla; Noeleen De Angelis; Lidia Staszewsky; Roberto Latini; Tiziana Crepaldi
Journal:  Transgenic Res       Date:  2011-03-01       Impact factor: 2.788

4.  Polycomb repressive complex 2 regulates normal development of the mouse heart.

Authors:  Aibin He; Qing Ma; Jingjing Cao; Alexander von Gise; Pingzhu Zhou; Huafeng Xie; Bing Zhang; Michael Hsing; Danos C Christodoulou; Patrick Cahan; George Q Daley; Sek Won Kong; Stuart H Orkin; Christine E Seidman; Jonathan G Seidman; William T Pu
Journal:  Circ Res       Date:  2011-12-08       Impact factor: 17.367

5.  Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.

Authors:  Vinciane Gaussin; Tom Van de Putte; Yuji Mishina; Mark C Hanks; An Zwijsen; Danny Huylebroeck; Richard R Behringer; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  APC controls asymmetric Wnt/β-catenin signaling and cardiomyocyte proliferation gradient in the heart.

Authors:  Bo Ye; Ning Hou; Lu Xiao; Yifan Xu; James Boyer; Haodong Xu; Faqian Li
Journal:  J Mol Cell Cardiol       Date:  2015-10-19       Impact factor: 5.000

7.  Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.

Authors:  Cordula M Wolf; Michael Arad; Ferhaan Ahmad; Atsushi Sanbe; Scott A Bernstein; Okan Toka; Tetsuo Konno; Gregory Morley; Jeffrey Robbins; J G Seidman; Christine E Seidman; Charles I Berul
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

8.  Transient and transgenic analysis of the zebrafish ventricular myosin heavy chain (vmhc) promoter: an inhibitory mechanism of ventricle-specific gene expression.

Authors:  Ruilin Zhang; Xiaolei Xu
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

9.  Activated Met signalling in the developing mouse heart leads to cardiac disease.

Authors:  Christian Leo; Valentina Sala; Mara Morello; Amedeo Chiribiri; Ilan Riess; Daniele Mancardi; Stefano Schiaffino; Carola Ponzetto; Tiziana Crepaldi
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

10.  The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.

Authors:  Marcella Neri; Emanuele Valli; Giovanna Alfano; Matteo Bovolenta; Pietro Spitali; Claudio Rapezzi; Francesco Muntoni; Sandro Banfi; Giovanni Perini; Francesca Gualandi; Alessandra Ferlini
Journal:  BMC Med Genet       Date:  2012-03-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.